Healthcare spending to double by 2030: Bain report
Upper-middle-income households becoming the biggest demographic in 2030 will drive healthcare services.
complex generics
September 2019
August 2018
The toughest period is behind us: Vinita Gupta
India’s third-largest generic drugmaker Lupin is focussing on building a pipeline of specialty drugs, while cutting costs and addressing regulatory concerns.
‘New complex generics to augur well for Lupin’
Vinita Gupta is confident that new complex generics, specialty drugs and manufacturing quality enhancement plan will augur well for the company
